Pulmonary arterial hypertension in breast cancer patients on HER2-targeted therapy: A review of FDA adverse events reporting system data

Godsfavour Umoru; Matthew Taitano; Sarah Beshay; Polly Niravath; Sandeep Sahay

doi:10.1183/23120541.00199-2020

Pulmonary arterial hypertension in breast cancer patients on HER2-targeted therapy: A review of FDA adverse events reporting system data

Godsfavour Umoru, Matthew Taitano, Sarah Beshay, Polly Niravath, Sandeep Sahay

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Article number	00199-2020
Pages (from-to)	1-3
Number of pages	3
Journal	ERJ Open Research
Volume	6
Issue number	2
DOIs	https://doi.org/10.1183/23120541.00199-2020
State	Published - Apr 1 2020

ASJC Scopus subject areas

Pulmonary and Respiratory Medicine

Divisions

Medical Oncology
Pulmonary, Critical Care and Sleep Medicine

Access to Document

10.1183/23120541.00199-2020

Cite this

@article{0a8be83d95974bebb4db2a61dbf3b250,

title = "Pulmonary arterial hypertension in breast cancer patients on HER2-targeted therapy: A review of FDA adverse events reporting system data",

author = "Godsfavour Umoru and Matthew Taitano and Sarah Beshay and Polly Niravath and Sandeep Sahay",

year = "2020",

month = apr,

day = "1",

doi = "10.1183/23120541.00199-2020",

language = "English (US)",

volume = "6",

pages = "1--3",

journal = "ERJ Open Research",

issn = "2312-0541",

publisher = "European Respiratory Society",

number = "2",

}

TY - JOUR

T1 - Pulmonary arterial hypertension in breast cancer patients on HER2-targeted therapy

T2 - A review of FDA adverse events reporting system data

AU - Umoru, Godsfavour

AU - Taitano, Matthew

AU - Beshay, Sarah

AU - Niravath, Polly

AU - Sahay, Sandeep

PY - 2020/4/1

Y1 - 2020/4/1

UR - https://www.scopus.com/pages/publications/85114078425

UR - https://www.scopus.com/inward/citedby.url?scp=85114078425&partnerID=8YFLogxK

U2 - 10.1183/23120541.00199-2020

DO - 10.1183/23120541.00199-2020

M3 - Letter

AN - SCOPUS:85114078425

SN - 2312-0541

VL - 6

SP - 1

EP - 3

JO - ERJ Open Research

JF - ERJ Open Research

IS - 2

M1 - 00199-2020

ER -

Pulmonary arterial hypertension in breast cancer patients on HER2-targeted therapy: A review of FDA adverse events reporting system data

ASJC Scopus subject areas

Divisions

Access to Document

Other files and links

Cite this